ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 326408 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 326408; 2) Community: the network communities that were significantly associated with the response to NSC 326408; 3) Molecule: the relationships between components within communities and NSC 326408; 4) MDR: the compounds that were significantly associated with the NSC 326408.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0237269271456697 -0.26776269
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0237269271456697 0.42336391
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0237269271456697 0.36734497
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0237269271456697 0.52529818
NSC 750050 Null 0.0237269271456697 0.30738334
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0237269271456697 0.21741356
NSC 372939 Null 0.0291420747327558 0.58405776
NSC 48956 Null 0.0291420747327558 0.29837961
NSC 616362 2-Methoxycarbonyl-3,4-dichloro-5-nitrofuran 0.0291420747327558 0.32232864
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.0291420747327558 0.31815766
Total:100  Current:62    [First] [Prev] [Next] [Last]